Bioengineers and life scientists incorporate hybridoma technology to produce large numbers of identical antibodies, and develop new antibody therapeutics and diagnostics. Recent preclinical and clinical studies on the technology ...
COVID is not yet under control. Despite a bevy of vaccines, monoclonal antibodies, and antivirals, the virus continues to mutate and elude us. One solution that scientists have been exploring since the early days of the pandemic ...
Bio & Medicine
Mar 14, 2023
0
104
Like the Roadrunner outwitting Wile E. Coyote, SARS-CoV-2 (the infectious virus responsible for COVID-19) keeps mutating, generating new variants that can slip from the grip of a well-trained immune system or a well-aimed ...
Biochemistry
Sep 9, 2022
0
119
In a new report now published on Science, Robby Divine and an interdisciplinary research team at the department of biochemistry, regenerative medicine, and vaccines and infectious disease at the University of Washington U.S. ...
A new mathematical model describes how highly concentrated antibody solutions separate into different phases, similar to an oil and water mixture. This separation can reduce the stability and shelf-life of some drugs that ...
Materials Science
Jul 22, 2019
0
150
Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer—one of the most aggressive and difficult to treat cancers—by delivering immunotherapy directly into the tumor with a device that is ...
Bio & Medicine
Apr 13, 2023
0
1801
Carbon nanotubes (CNTs) have become a mainstay of the field of nanotechnology. Finding innovative applications across materials science, electronics, and medicine, CNTs have garnered a lot of attention from researchers in ...
Bio & Medicine
Apr 6, 2023
0
152
Humans are colonized with thousands of bacterial strains. Researchers are now focused on genetically modifying such bacteria to enhance their intrinsic therapeutic properties.
Cell & Microbiology
Mar 31, 2023
0
85
An MUSC Hollings Cancer Center research team has created what team members believe to be among the first small molecules designed to stimulate immune cells to fight cancer. More importantly, these compounds inhibit a specific ...
Biochemistry
Feb 28, 2023
0
124
Using an approach based on CRISPR proteins, MIT researchers have developed a new way to precisely control the amount of a particular protein that is produced in mammalian cells.
Biotechnology
Nov 1, 2022
0
28
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
This text uses material from Wikipedia, licensed under CC BY-SA
